Information Request Form

Section:	Main.PHARMA..Drug BioAvailability.Oral Drug BioAvailability.Improvement..Essential Oils (USA.A).Patent.Literature (Claims Etc.).Claim 1: Oral BioAvailability of.Hydrophobic Drug Increase Method:.Co-Adm. Drug & Essential Oil or.Essential Oil Component to provide.Concn. of Essential Oil or Comp. in.Gut > than Concn. that Reduces.Cyclosporin (C) to Hydroxylated (C.) Conversion by 10% in Assay Contg..Rat Liver Microsomes (250 .mu.g).Cyclosporin (1 .mu.M),.& NADPH (1 mM) in.Sodium Phosphate Buffer (1 ml 0.1M).pH = 7.4. Claim 3: Pharma. Compn.:.Carrier, Drug & Essential Oil..Claim 5: Essential Oil or Component.as Counter-Ion of Drug. Claim 6:.Essential Oil or Component.Covalently Linked to Drug..Patent Assignee
Code:	52901
Product:	USA. A
Company or Organization:
Contact's name *:
Position:
E-mail:
Mailing address:
Phone number:
Fax number:
Fields of interest:	PATENT ASSIGNEE PATENT INVENTORS PATENT NUMBER
* If you are not linked to any company or organization complete at least this field